Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013.
作者信息
Pinheiro Marcelo Maia, Pinheiro Felipe Moura Maia
机构信息
UNIVAG Centro Universitário, Várzea Grande, Mato Grosso, Brazil.
Hospital das Clínicas, Faculdade de Medicina de São Paulo - Universidade de São Paulo, São Paulo, SP, Brazil.
出版信息
Diabetes Care. 2023 Nov 1;46(11):e209. doi: 10.2337/dc23-1115.
Abstract
摘要
相似文献
1
Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013.评论罗素等人的研究。阿巴西普延缓1型糖尿病进展在1期高危亲属中的应用：一项随机、双盲、对照试验。《糖尿病护理》2023年；46:1005 - 1013。
Diabetes Care. 2023 Nov 1;46(11):e209. doi: 10.2337/dc23-1115.
2
Response to Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013.对关于罗素等人的评论的回应。阿巴西普延缓1型糖尿病高危一级亲属疾病进展：一项随机、双盲、对照试验。《糖尿病护理》2023年；46:1005 - 1013。
Diabetes Care. 2023 Nov 1;46(11):e210-e211. doi: 10.2337/dci23-0050.
3
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.阿巴西普治疗 1 型糖尿病高危 1 期患者的进展：一项随机、双盲、对照试验。
Diabetes Care. 2023 May 1;46(5):1005-1013. doi: 10.2337/dc22-2200.
4
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.阿巴西普治疗近期发病 1 型糖尿病患者的共刺激调节作用：一项随机、双盲、安慰剂对照试验。
Lancet. 2011 Jul 30;378(9789):412-9. doi: 10.1016/S0140-6736(11)60886-6. Epub 2011 Jun 28.
5
B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetes.B 淋巴细胞改变伴随依那西普治疗新发 1 型糖尿病的耐药。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.126136.
6
In patients at high risk for RA, abatacept reduced inflammation and RA development at 6 mo.在有发生类风湿关节炎风险的患者中，阿巴西普在 6 个月时可减轻炎症和类风湿关节炎的发生。
Ann Intern Med. 2024 Jul;177(7):JC79. doi: 10.7326/ANNALS-24-00740-JC. Epub 2024 Jul 2.
7
Comment on Haidar et al. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes. Diabetes Care 2023;46:1372-1378.对海达尔等人的评论。一项随机交叉试验，比较1型糖尿病患者中自动胰岛素输注（人工胰腺）与碳水化合物计数或简化的定性餐量估计。《糖尿病护理》2023年；46:1372 - 1378。
Diabetes Care. 2023 Oct 1;46(10):e207-e208. doi: 10.2337/dc23-1243.
8
Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957.对拉塞尔 - 琼斯等人的评论。《糖尿病护理》2017年；40:943 - 950。对鲍林等人的评论。《糖尿病护理》2017年；40:951 - 957。
Diabetes Care. 2018 Mar;41(3):e27-e28. doi: 10.2337/dc17-1916.
9
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis.CTLA-4 Ig作为1型糖尿病合并血清学阳性类风湿关节炎患者的一种有效治疗方法。
Clin Exp Rheumatol. 2016 Mar-Apr;34(2):315-7. Epub 2015 Nov 17.
10
Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957.对关于拉塞尔 - 琼斯等人的评论的回应。《糖尿病护理》2017年；40:943 - 950。对鲍林等人的评论。《糖尿病护理》2017年；40:951 - 957。
Diabetes Care. 2018 Mar;41(3):e29-e30. doi: 10.2337/dci17-0051.
引用本文的文献
1
Response to Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013.对关于罗素等人的评论的回应。阿巴西普延缓1型糖尿病高危一级亲属疾病进展：一项随机、双盲、对照试验。《糖尿病护理》2023年；46:1005 - 1013。
Diabetes Care. 2023 Nov 1;46(11):e210-e211. doi: 10.2337/dci23-0050.
本文引用的文献
1
Efficacy of combination therapy with GABA, a DPP-4i and a PPI as an adjunct to insulin therapy in patients with type 1 diabetes.GABA、DPP-4i 和 PPI 联合治疗作为 1 型糖尿病胰岛素治疗辅助手段的疗效。
Front Endocrinol (Lausanne). 2023 May 24;14:1171886. doi: 10.3389/fendo.2023.1171886. eCollection 2023.
2
Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study.西格列汀联合维生素 D3（VIDPP-4i）治疗对新发 1 型糖尿病患者临床缓解的影响：一项回顾性病例对照研究。
Arch Endocrinol Metab. 2023 May 25;67(5):e000652. doi: 10.20945/2359-3997000000652.
3
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.阿巴西普治疗 1 型糖尿病高危 1 期患者的进展：一项随机、双盲、对照试验。
Diabetes Care. 2023 May 1;46(5):1005-1013. doi: 10.2337/dc22-2200.
4
Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes.探索性研究揭示了维拉帕米治疗 1 型糖尿病患者的深远的系统性和细胞性作用。
Nat Commun. 2022 Mar 3;13(1):1159. doi: 10.1038/s41467-022-28826-3.
5
Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes.维生素 D 和二肽基肽酶-4 抑制剂（VIDPP-4i）联合治疗自身免疫性糖尿病的免疫调节疗法。
Int Immunopharmacol. 2021 Jun;95:107518. doi: 10.1016/j.intimp.2021.107518. Epub 2021 Mar 20.
Zotero 插件